ブラキセラピーの市場規模、シェア、成長分析、製品タイプ別、技術別、エンドユーザー別、用途別、地域別 - 産業予測、2025年～2032年

ブラキセラピーの市場規模は2023年に8億米ドルと評価され、2024年の8億7,000万米ドルから2032年には16億4,000万米ドルに成長し、予測期間（2025年～2032年）のCAGRは8.3％で成長する見通しです。

ブラキセラピーの世界市場は、がんの有病率の上昇と継続的な技術進歩により、大きな成長が見込まれています。ブラキセラピーは、放射性物質をカテーテルを通して体内に直接入れることで標的放射線を照射し、局所腫瘍の治療に高い効果を発揮します。国際がん研究機関（IARC）は、2030年までに世界のがん罹患数が1,930万人から2,460万人に増加すると予測しており、ブラキセラピーの需要は増加傾向にあります。根治治療から緩和治療まで、その治療の多様性と、精度を高め健康な組織へのダメージを最小限に抑える最近の技術革新が相まって、医師の間で採用率が高まっています。特に米国市場は、放射線治療への継続的な投資と関心を反映して、今後数年間は堅調なCAGRを維持すると予想されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 主要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

ブラキセラピーの市場規模：製品タイプ別 & CAGR（2025年～2032年）

• 市場概要
• シード
• アプリケーターとアフターローダー
• 電子ブラキセラピー

ブラキセラピーの市場規模：技術別 & CAGR（2025年～2032年）

• 市場概要
• 高線量率（HDR）
• 低線量率（LDR）

ブラキセラピーの市場規模：エンドユーザー別 & CAGR（2025年～2032年）

• 市場概要
• 病院
• 専門クリニック
• その他

ブラキセラピーの市場規模：用途別 & CAGR（2025年～2032年）

• 市場概要
• 婦人科がん
• 前立腺がん
• 乳がん
• その他

ブラキセラピーの市場規模 & CAGR（2025年～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022年～2024年）

主要企業プロファイル

• Elekta（スウェーデン）
• Becton, Dickinson and Company（米国）
• Eckert & Ziegler（ドイツ）
• Theragenics（米国）
• iCAD（米国）
• CIVCO Medical Solutions（米国）
• Isoray Medical（米国）
• Best Medical International（米国）
• AngioDynamics（米国）
• Carl Zeiss Meditec（ドイツ）
• Nordion（カナダ）
• Oncura（英国）
• Sensus Healthcare（米国）
• IBA（ベルギー）
• RaySearch Laboratories（スウェーデン）
• ViewRay（米国）

結論と提言

Brachytherapy Market size was valued at USD 0.8 billion in 2023 and is poised to grow from USD 0.87 billion in 2024 to USD 1.64 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global brachytherapy market is poised for significant growth, driven by the rising prevalence of cancer and continuous technological advancements. Brachytherapy delivers targeted radiation by placing radioactive materials directly inside the body through catheters, making it highly effective for treating localized tumors. With the International Agency for Research on Cancer (IARC) projecting a rise in global cancer incidences from 19.3 million to 24.6 million by 2030, the demand for brachytherapy is on the rise. Its versatility in treatment-ranging from curative to palliative care-combined with recent innovations that enhance precision and minimize damage to healthy tissues, has increased adoption rates among physicians. The U.S. market is particularly expected to sustain a robust CAGR in the coming years, reflecting continued investment and interest in radiation therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Brachytherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Brachytherapy Market Segments Analysis

Global Brachytherapy Market is segmented by Product Type, Technique, End User, Application and region. Based on Product Type, the market is segmented into Seeds, Applicators and Afterloaders and Electronic Brachytherapy. Based on Technique, the market is segmented into High Dose Rate (HDR) and Low Dose Rate (LDR). Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on Application, the market is segmented into Gynecological Cancer, Prostate Cancer,breast cancerand Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Brachytherapy Market

The brachytherapy market is experiencing significant growth driven by the rising preference for minimally invasive treatment options among patients. These procedures are favored for their associated benefits, such as fewer post-operative complications, shorter hospital stays, and expedited recovery times. Brachytherapy stands out as a viable minimally invasive alternative, often allowing for outpatient treatment in numerous cases. As more patients seek options that minimize their recovery period and overall discomfort, the demand for these innovative procedures continues to escalate, further propelling the advancement and expansion of the brachytherapy market.

Restraints in the Brachytherapy Market

The Brachytherapy market faces significant restraints due to the necessity of specialized equipment and infrastructure needed for effective treatment planning, radiation delivery, and ensuring patient safety. The initial investment required for purchasing and installing this equipment can be substantial, presenting a financial barrier for many healthcare facilities. This is particularly pronounced in resource-limited areas where budgets may already be stretched thin. As a result, the substantial upfront costs can hinder the widespread adoption of brachytherapy technologies, limiting access to treatment and impeding market growth in certain regions, despite the benefits and effectiveness of the therapy itself.

Market Trends of the Brachytherapy Market

The brachytherapy market is witnessing a significant upward trend driven by the growing preference for organ-preserving treatments across various cancer types, particularly prostate, breast, and cervical cancers. This targeted radiation therapy minimizes collateral damage to healthy tissues, enhancing organ function and significantly improving patients' quality of life. As healthcare shifts towards more minimally invasive approaches, the adoption of brachytherapy is increasing, reinforced by advancements in technology and techniques that further improve treatment efficacy and safety. This trend aligns with patients and providers prioritizing personalized care, thereby establishing brachytherapy as a crucial modality in contemporary oncology practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Brachytherapy Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Seeds
• Applicators and Afterloaders
• Electronic Brachytherapy

Global Brachytherapy Market Size by Technique & CAGR (2025-2032)

• Market Overview
• High Dose Rate (HDR)
• Low Dose Rate (LDR)

Global Brachytherapy Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Brachytherapy Market Size by Application & CAGR (2025-2032)

• Market Overview
• Gynecological Cancer
• Prostate Cancer
• Breast Cancer
• Others

Global Brachytherapy Market Size & CAGR (2025-2032)

• North America (Product Type, Technique, End User, Application)
  • US
  • Canada
• Europe (Product Type, Technique, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technique, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technique, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technique, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Elekta (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theragenics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iCAD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CIVCO Medical Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isoray Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Medical International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oncura (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensus Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViewRay (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations